Inhibition of GABA metabolism by β-lactam antibiotics affects encystation in Acanthamoeba

Chih-Ming Tsai1, Yao-Tsung Chang2, Yu-Jen Wang3

  • 1Department of Parasitology, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Insights

γ-aminobutyric acid (GABA) accumulation drives Acanthamoeba encystation, leading to drug resistance in Acanthamoeba keratitis (AK). Beta-lactam antibiotics targeting GABA pathways show promise in inhibiting cyst formation and improving AK treatment.

Area of Science:

  • Microbiology
  • Parasitology
  • Molecular Biology

Background:

  • Acanthamoeba keratitis (AK) is a severe corneal infection often resistant to treatment due to parasite cyst formation.
  • Current therapies struggle against drug-resistant Acanthamoeba cysts, necessitating novel treatment strategies.

Purpose of the Study:

  • To investigate the role of γ-aminobutyric acid (GABA) in Acanthamoeba encystation.
  • To explore the potential of β-lactam antibiotics as anti-encystation agents for AK treatment.

Main Methods:

  • Metabolomic profiling and gene expression analysis to identify key molecules in encystation.
  • In vitro experiments to assess the effect of exogenous GABA and β-lactam antibiotics on Acanthamoeba cyst formation.

Main Results:

  • Significant accumulation of GABA and upregulation of GABA shunt pathway genes (GDH, GAD) during encystation.
  • Exogenous GABA enhanced encystation rates and associated gene expression.
  • β-lactam antibiotics (cefotaxime, carbenicillin, penicillin G) significantly inhibited cyst formation without cytotoxicity, unlike non-β-lactam antibiotics.

Conclusions:

  • GABA metabolism is critical for Acanthamoeba encystation.
  • β-lactam antibiotics may overcome drug resistance in AK by interfering with GABA-mediated signaling pathways.
  • β-lactam antibiotics represent potential adjunctive therapies for Acanthamoeba keratitis.

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
863
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
404
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K